Major study on DMT shows promise for depression
One of the largest studies for a short-acting psychedelic showed a remission rate of 57 percent for MDD after a single dose of DMT.
Source: europeanpharmaceuticalreview.com
Page 19 - Small Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Small Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Small Pharma Today - Breaking & Trending Today
Small Pharma Reports Fiscal Third Quarter 2023 Highlights
Positive top-line results from Phase IIa trial of SPL026 in Major Depressive Disorder New SPL026 trials underway and screening commenced in the first...
Source: globenewswire.com
Small Pharma Inc Stock Quote | Stock Price for DMTTF | FinancialContent Business Page
FinancialContent fully hosted finance channel
Source: financialcontent.com
Psyched: Canada's Psychedelic Therapy Guidelines, $39M Series B For Next-Gen Drugs, Mexico's Ancestral Roots & More
Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries The agency regulating all things ...
Source: businessinsider.com
Small Pharma To Support University College London Research Project on Neuroplasticity
LONDON, Dec. 14, 2022 -- Small Pharma Inc. , a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announces that it will provide its... | December 15, 2022
Source: marketscreener.com